Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma

JOURNAL OF CLINICAL IMMUNOLOGY

SPRINGER/PLENUM PUBLISHERS

1. Chan Zuckerberg Biohub Initiative
2. National Institute of Diabetes, Digestive and Kidney Disease [1F30DK123915-01]
3. National Institute of Allergy and Infectious Diseases [5P01AI118688-04]
4. National Institute of General Medical Sciences [5T32GM007618-42]
5. UCSF Medical Scientist Training Program
6. MD-PhD program of the Imagine Institute
7. Fondation Bettencourt-Schueller
8. Howard Hughes Medical Institute
9. Rockefeller University
10. National Institutes of Health (NIH) [R01AI088364]
11. National Center for Advancing Translational Sciences (NCATS)
12. NIH Clinical and Translational Science Award (CTSA) program [UL1 TR001866]
13. St. Giles Foundation
14. Fast Grant from Emergent Ventures
15. Mercatus Center at George Mason University
16. Yale Center for Mendelian Genomics
17. GSP Coordinating Center - National Human Genome Research Institute (NHGRI) [UM1HG006504, U24HG008956]
18. Fisher Center for Alzheimer's Research Foundation
19. Meyer Foundation
20. French National Research Agency (ANR) under the Investments for the Future program [ANR-10-IAHU-01]
21. Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence [ANR10-LABX-62-IBEID]
22. French Foundation for Medical Research (FRM) [EQU201903007798]
23. FRM
24. ANR GENCOVID project [ANRS-COV05]
25. Square Foundation
26. Grandir-Fonds de solidarite pour l'enfance
27. SCOR Corporate Foundation for Science
28. Institut National de la Sante et de la Recherche Medicale (INSERM)
29. University of Paris